Desaloms J M, Krauss J K, Lai E C, Jankovic J, Grossman R G
Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA.
J Neurosurg. 1998 Aug;89(2):194-9. doi: 10.3171/jns.1998.89.2.0194.
The goal of this study was to investigate the impact of mild or moderate degrees of degenerative or ischemic encephalopathy on predicting clinical outcome following unilateral posteroventral medial pallidotomy for treatment of advanced Parkinson's disease (PD).
Thirty-five patients with PD were studied prospectively. The presence and degree of cortical atrophy, ventriculomegaly, deep white matter lesions (DWML), periventricular lucencies (PVL), and the presence of lacunes and status cribriformis (multiple and bilateral enlarged Virchow-Robin spaces) were determined by magnetic resonance (MR) imaging before the patients underwent stereotactic pallidotomy performed according to a standard protocol. Clinical outcome was measured using a standard battery of tests including application of the Unified Parkinson's Disease Rating Scale (UPDRS). The preoperative MR imaging features were correlated with UPDRS subscores such as motor "off' score, the activities of daily living (ADL) off score, the off subscore for bradykinesia, the percentage of "on" time dyskinesias, and a global outcome rating. The MR findings were also correlated with the occurrence of side effects. Global outcome was rated as markedly improved in 22 patients (63%) and as moderately improved in 12 patients (34%) 6 months postoperatively. At the 1-year follow-up examination, global outcome in 31 patients was rated as markedly improved in 14 patients (45%), as moderately improved in another 14 (45%), as slightly improved in two (6%), and as worse in one patient (3%). The mean UPDRS motor off score changed from 58.7 preoperatively to 33.2 at 6 months and 33.4 at 1 year (p < 0.0001), the ADL off score from 31.8 to 18.2 at 6 months and 18.6 at 1 year (p < 0.0001), the off score from contralateral bradykinesia from 11.6 to 5.6 at 6 months and 4.1 at 1 year (p < 0.0001), and the percentage of awake time with dyskinesias from 37.4 to 17.4% at 6 months and 21.1% at 1 year (p < 0.0001). The presence of mild or moderate degrees of cortical atrophy, PVL, and DWML had no effect on clinical outcome. Patients with status cribriformis and those with lacunes tended to show comparatively less improvement in the UPDRS ADL off score (p = 0.014 and p = 0.016, respectively) at 6 months. This tendency was also present in patients with status cribriformis 1 year postoperatively (p = 0.046). Patients with both status cribriformis and lacunes had a higher incidence of transient altered mental status immediately postoperatively (p = 0.05).
Mild-to-moderate degrees of cortical atrophy, ventriculomegaly, and ischemic encephalopathy do not predispose patients to less favorable outcomes following unilateral pallidotomy. Patients with both status cribriformis and lacunes have a higher risk of transient side effects; however, with regard to clinical outcome, these patients should not be denied surgical treatment.
本研究旨在探讨轻度或中度退行性或缺血性脑病对预测晚期帕金森病(PD)单侧后腹内侧苍白球切开术临床结局的影响。
对35例帕金森病患者进行前瞻性研究。在患者按照标准方案接受立体定向苍白球切开术之前,通过磁共振(MR)成像确定皮质萎缩、脑室扩大、深部白质病变(DWML)、脑室周围透亮区(PVL)的存在及程度,以及腔隙和筛状状态(多个双侧扩大的Virchow-Robin间隙)。使用包括统一帕金森病评定量表(UPDRS)在内的标准测试组合来测量临床结局。术前MR成像特征与UPDRS子评分相关,如运动“关”期评分、日常生活活动(ADL)“关”期评分、对侧运动迟缓“关”期评分、异动症“开”期时间百分比以及总体结局评分。MR检查结果也与副作用的发生相关。术后6个月,22例患者(63%)的总体结局被评为明显改善,12例患者(34%)为中度改善。在1年随访检查时,31例患者中,14例(45%)的总体结局被评为明显改善,另外14例(45%)为中度改善,2例(6%)为轻度改善,1例患者(3%)为恶化。UPDRS运动“关”期评分术前平均为58.7,术后6个月为33.2,1年时为33.4(p < 0.0001);ADL“关”期评分从术前的31.8降至术后6个月的18.2和1年时的18.6(p < 0.0001);对侧运动迟缓“关”期评分从11.6降至术后6个月的5.6和1年时的4.1(p < 0.0001);异动症清醒时间百分比从术前的37.4%降至术后6个月的17.4%和1年时的21.1%(p < 0.0001)。轻度或中度皮质萎缩、PVL和DWML的存在对临床结局无影响。筛状状态患者和腔隙患者在术后6个月时UPDRS ADL“关”期评分的改善相对较少(分别为p = 0.014和p = 0.016)。术后1年,筛状状态患者也存在这种趋势(p = 0.046)。同时患有筛状状态和腔隙的患者术后立即出现短暂精神状态改变的发生率较高(p = 0.05)。
轻度至中度皮质萎缩、脑室扩大和缺血性脑病不会使患者在单侧苍白球切开术后预后较差。同时患有筛状状态和腔隙的患者出现短暂副作用的风险较高;然而,就临床结局而言,不应拒绝这些患者接受手术治疗。